Equillium (FRA:0FY) Days Sales Outstanding : 0.00 (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Equillium Days Sales Outstanding?

Equillium's average Accounts Receivable for the three months ended in Mar. 2025 was €0.00 Mil. Equillium's Revenue for the three months ended in Mar. 2025 was €0.00 Mil.

The historical rank and industry rank for Equillium's Days Sales Outstanding or its related term are showing as below:

FRA:0FY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.17 Med: 33.24 Max: 65.73
Current: 58.72

During the past 8 years, Equillium's highest Days Sales Outstanding was 65.73. The lowest was 33.17. And the median was 33.24.

FRA:0FY's Days Sales Outstanding is ranked better than
60.07% of 844 companies
in the Biotechnology industry
Industry Median: 70.135 vs FRA:0FY: 58.72

Equillium's Days Sales Outstanding declined from Mar. 2024 (37.44) to Mar. 2025 (0.00).

Equillium Days Sales Outstanding Historical Data

The historical data trend for Equillium's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Equillium Days Sales Outstanding Chart

Equillium Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

65.73

33.67

31.85

Equillium Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															37.44	35.88	45.60	-	-

Competitive Comparison of Equillium's Days Sales Outstanding

For the Biotechnology subindustry, Equillium's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Equillium's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Equillium's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Equillium's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Equillium Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Equillium's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (3.425	+	0)	/	1 )	/	39.246	*	365
=	3.425					/	39.246	*	365
=	31.85

Equillium's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365 / 4
=	0					/	0	*	365 / 4
=	N/A

Equillium (FRA:0FY) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Equillium Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Equillium's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Equillium Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Equillium Inc (FRA:0FY) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

EQ:USA 0A4D:UK

Address

2223 Avenida De La Playa, Suite 105, La Jolla, CA, USA, 92037

Website

https://www.equilliumbio.com

Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.

Equillium Headlines

No Headlines